Novo Holdings A S' Q4 2023 13F: 3 new positions, 7 exits
Form 13F-HR for the quarter ended Dec 31, 2023 · filed Feb 14, 2024 · 36 reported positions · accession 0000950123-24-002161
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | DISC MEDICINE, INC. (IRON) | 3.8% | — | −3.8 pts | −1.09M sh | −100% |
| Exited | ARCELLX, INC. (ACLX) | 2.9% | — | −2.9 pts | −1.08M sh | −100% |
| Exited | SEAGEN INC. (SGEN) | 2.5% | — | −2.5 pts | −160K sh | −100% |
| Reduced | CORCEPT THERAPEUTICS INC (CORT) | 6.8% | 4.8% | −2.0 pts | −966K sh | −29% |
| Exited | RENEO PHARMACEUTICALS INC (RPHM) | 1.9% | — | −1.9 pts | −3.33M sh | −100% |
| New | CARGO THERAPEUTICS INC (CRGX) | — | 1.8% | +1.8 pts | +1.25M sh | new |
| New | VERVE THERAPEUTICS INC (VERV) | — | 1.7% | +1.7 pts | +2M sh | new |
| New | LEXEO THERAPEUTICS INC (LXEO) | — | 1.1% | +1.1 pts | +1.31M sh | new |
| Reduced | CYMABAY THERAPEUTICS INC (CBAY) | 1.7% | 1.3% | −0.4 pts | −667K sh | −43% |
| Reduced | BLUEPRINT MEDICINES CORP (BPMC) | 1.9% | 2.0% | +0.1 pts | −166K sh | −32% |
| Increased | 4D MOLECULAR THERAPEUTICS IN (FDMT) | 1.1% | 1.9% | +0.7 pts | +300K sh | +25% |
| Exited | SILK RD MED INC (SILK) | 0.4% | — | −0.4 pts | −334K sh | −100% |
| Increased | PHARVARIS N V (PHVS) | 2.1% | 2.7% | +0.6 pts | +210K sh | +16% |
| Increased | AMICUS THERAPEUTICS INC (FOLD) | 1.9% | 2.2% | +0.3 pts | +404K sh | +19% |
| Increased | BIOMARIN PHARMACEUTICAL INC (BMRN) | 2.6% | 2.7% | +0.1 pts | +50,000 sh | +13% |
| Exited | CYTEIR THERAPEUTICS INC (CYT) | 0.1% | — | −0.1 pts | −676K sh | −100% |
| Increased | ROCKET PHARMACEUTICALS INC (RCKT) | 1.5% | 1.9% | +0.4 pts | +49,000 sh | +5% |
| Exited | KINNATE BIOPHARMA INC (KNTE) | 0.1% | — | −0.1 pts | −816K sh | −100% |
| Increased | INSPIRE MED SYS INC (INSP) | 0.9% | 0.8% | −0.1 pts | +5,524 sh | +9% |
| Reduced | RALLYBIO CORP (RLYB) | 0.5% | 0.3% | −0.3 pts | −420K sh | −19% |
| Reduced | LAVA THERAPEUTICS NV (LVTX) | 0.3% | 0.2% | −0.1 pts | −522K sh | −22% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 60.9% of the equity book
Changes in the top 10 this quarter: SPRO entered · EWTX entered · PCVX entered · IRON left · MIRM left · BABA left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | BROOKFIELD CORP (BN) | 9.0% | 9.6% | |
| 2 | ASML HOLDING N V (ASML) | 8.6% | 9.2% | |
| 3 | SALESFORCE.COM, INC. (CRM) | 7.9% | 8.6% | |
| 4 | SPERO THERAPEUTICS INC (SPRO) | 0.0% | 7.6% | Entered the top 10 |
| 5 | LANZATECH GLOBAL INC (LNZA) | 5.5% | 4.9% | |
| 6 | CORCEPT THERAPEUTICS INC (CORT) | 6.8% | 4.8% | |
| 7 | TAIWAN SEMICONDUCTOR MFG LTD (TSM) | 4.6% | 4.6% | |
| 8 | EDGEWISE THERAPEUTICS INC (EWTX) | 2.6% | 4.1% | Entered the top 10 |
| 9 | CABLE ONE INC (CABO) | 5.4% | 4.1% | |
| 10 | VAXCYTE INC (PCVX) | 3.2% | 3.3% | Entered the top 10 |
| — | DISC MEDICINE, INC. (IRON) | 3.8% | 0.0% | Left the top 10 |
| — | MIRUM PHARMACEUTICALS INC (MIRM) | 3.5% | 2.7% | Left the top 10 |
| — | ALIBABA GROUP HLDG LTD (BABA) | 3.2% | 2.4% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).